首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   27387篇
  免费   2337篇
  国内免费   982篇
耳鼻咽喉   129篇
儿科学   522篇
妇产科学   272篇
基础医学   8620篇
口腔科学   409篇
临床医学   2382篇
内科学   4765篇
皮肤病学   883篇
神经病学   813篇
特种医学   273篇
外国民族医学   12篇
外科学   1658篇
综合类   3806篇
现状与发展   5篇
预防医学   876篇
眼科学   207篇
药学   1483篇
  1篇
中国医学   445篇
肿瘤学   3145篇
  2024年   39篇
  2023年   264篇
  2022年   469篇
  2021年   688篇
  2020年   601篇
  2019年   671篇
  2018年   706篇
  2017年   697篇
  2016年   786篇
  2015年   1017篇
  2014年   1395篇
  2013年   1706篇
  2012年   1445篇
  2011年   2015篇
  2010年   1711篇
  2009年   1870篇
  2008年   1675篇
  2007年   1664篇
  2006年   1563篇
  2005年   1415篇
  2004年   1262篇
  2003年   1139篇
  2002年   954篇
  2001年   769篇
  2000年   663篇
  1999年   583篇
  1998年   553篇
  1997年   419篇
  1996年   427篇
  1995年   428篇
  1994年   337篇
  1993年   253篇
  1992年   138篇
  1991年   132篇
  1990年   64篇
  1989年   40篇
  1988年   22篇
  1987年   9篇
  1986年   7篇
  1985年   13篇
  1984年   27篇
  1983年   12篇
  1982年   13篇
  1981年   15篇
  1980年   3篇
  1979年   8篇
  1978年   5篇
  1977年   6篇
  1975年   3篇
  1974年   2篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
脐血CD34+细胞体外定向诱导分化为T淋巴细胞的实验研究   总被引:1,自引:0,他引:1  
目的:建立利用人造血干/祖细胞体外定向诱导分化为T淋巴细胞的方法,为研究T细胞生物学特性及细胞免疫提供技术平台。方法:MACS方法分离人脐带CD34^ 细胞接种到人胎儿胸腺基质单层细胞上,IMDM液体培养基含20%人AB血清并加入FL、IL-12、IL-7和IL-2细胞因子组合,于培养7、14、21、28、35、42天取非贴壁细胞利用流式细胞仪对细胞表型进行检测,并进行细胞形态学分析。结果:2周后,CD4^ CD8^ 非成熟T淋巴细胞占细胞总数的0.3%-13.3%,4-5周CD4^ CD8^ T淋巴细胞达到高峰占16.6%-26.5%,且CD3^ CD4^ CD8^ 和CD3^ CD4^-CD8^ T淋巴细胞逐渐增多,6周后达26.5%~64.9%和11.6%-38.9%。培养成熟的T淋巴细胞经PHA IL-2刺激后瑞氏染色鉴定可见大原始淋巴细胞存在。结论:利用人脐血CD34^ 在体外人胎儿胸腺基质单层细胞上加FL、IL-12、IL-7和IL-2细胞因子组合条件下,可诱导分化出T淋巴细胞,并且培养的T细胞对有丝分裂素刺激有增殖反应。  相似文献   
92.
It has been suggested for many years that the regulation of the immune system for the maintenance of peripheral tolerance may involve regulatory/suppressor T cells. In the past few years, several investigators have demonstrated that these cells can be generated in vitro. It has also been shown that they can inhibit the progression of various autoimmune disease models when infused into susceptible mice. We have generated two murine T cell lines in the presence of KLH-specific T cell clones from BALB/c or DBA2 mice. The lines are characterized by a low proliferative response to mitogens, the capacity to secrete high amounts of IL-10 and TGF-beta, and small amounts of IFN-gamma. Interestingly, these cells are unable to produce IL-2, IL-4 or IL-5. The study of the surface phenotype of both lines revealed CD4+, CD25high, CD44low and CTLA-4- cells. When injected intravenously in (CBy.D2) F1 mice, these cells were able to inhibit 50-100% of the TNP-specific antibody production, when the hapten was coupled to KLH. In the present study we offer another evidence for the existence of regulatory T cells in the T lymphocyte repertoire, suggesting that they can also regulate immune responses to foreign antigens. Furthermore, we demonstrate an alternative pathway to generate these cells different from approaches used thus far.  相似文献   
93.
CD44 is a family of cell adhesion molecules involved in a variety of cellular functions. The present study analysed the expression of two CD44 isoforms in serous effusions of patients diagnosed with ovarian carcinoma and corresponding primary and metastatic lesions. Fifty-eight effusions, 23 primary ovarian tumours, and 44 metastatic lesions were studied for protein expression of CD44s and v3-10 using immunohistochemistry. Results were correlated with clinical parameters. CD44v3-10 was seen in carcinoma cells in the majority of cases at all sites. Malignant effusions showed an up-regulation of CD44s compared to both primary tumours and metastatic solid lesions. Mesothelial cells frequently expressed CD44s, but were rarely immunoreactive for v3-10. CD44s immunoreactivity in cancer cells in effusions was significantly more often observed in patients with FIGO stage 3 than in stage 4 patients (P = 0.045). Staining results did not correlate with age, effusion site, metastatic site, tumour grade or residual tumour mass after initial surgery. Likewise, comparison of overall and disease-free survival with expression of the CD44 isoforms studied did not reveal any statistically significant associations. The up-regulation in CD44 levels in effusions, primarily in stage 3 disease, suggests that adhesion of ovarian carcinoma cells to mesothelium may be regulated at the level of CD44s expression, and provides further evidence of phenotypic alteration in the transition from primary tumour cell clones to effusions. The similar expression profile of CD44 in carcinoma cells in peritoneal and pleural effusions supports our previous observations and the hypothesis that carcinoma cells in peritoneal effusions are truly metastatic. This revised version was published online in July 2006 with corrections to the Cover Date.  相似文献   
94.
目的:观察正常真皮内的单核-巨噬细胞和树枝状细胞的分布、排列规律,探讨单核-巨噬细胞在皮肤免疫防御中的作用。方法:正常皮肤8例,取面部、躯干、四肢近端、四肢远端、手掌和足跖6个部位皮肤,进行纵行与水平切片。CD1a和CD68单克隆抗体染色,观察朗格汉斯细胞(LC)和单核.巨噬细胞的分布形态和密度。结果:真皮浅层CD68阳性细胞呈网状分布,其密度为361-562个/mm^2。真皮内血管周围及附属器周围亦见CD68阳性细胞。真皮深层CD68阳性细胞多为树枝状,散在分布于粗大的胶原纤维之间。不同解剖部位真皮浅层CD68阳性细胞密度分别为:四肢远端562个/mm^2,腹部517个/mm^2,面部509个/mm^2,手掌507个/mm^2,四肢近端472个/mm^2,足跖361个/mm^2。真皮浅层CD68阳性细胞在手掌和足跖部位高于相应部位的表皮内CD1a和CD68细胞。结论:在真皮浅层形成数层单核.巨噬细胞网,此网在接近真表皮交界处较致密。真皮内单核-巨噬细胞的这种分布形式说明这些细胞在真皮内有明确的方向性,其防御的方向是穿透表皮进入真皮的入侵物。  相似文献   
95.
To study the determinants of CD4% and CD4 counts among HIV-negative Ethiopians, and to identify factors susceptible to explain the low CD4 counts observed among Ethiopian subjects. Cohort studies among factory workers in Akaki and Wonji, Ethiopia. Clinical and laboratory examinations, including determination of HIV serological status and T-cell subsets, were performed during follow-up visits every six months. In addition, micronutrients (retinol, carotenoids, tocopherol, transferrin receptor, and selenium) plasma concentrations were determined in a subset of 38 HIV-positive and 121 HIV-negative participants. HIV-negative participants with at least one CD4 count measurement were 157 females in Akaki, 203 males in Akaki, and 712 males in Wonji. CD4 counts were independently and positively associated with body mass index (through an increase in lymphocyte counts), female gender (through an increase in CD4%), cigarette smoking (through an increase in CD4%), khat chewing (through an increase in both lymphocyte counts and CD4%), and Akaki study site (through a large increase in lymphocyte counts compensating a decrease in CD4%). Intestinal parasitic infections were not associated with CD4% or CD4 counts. Retinol, carotenoids, and -tocopherol plasma concentrations decreased with HIV infection and advancing immunosuppression, but were not associated with CD4 counts among HIV-negative subjects. Low body mass index among Ethiopians may have contributed to their overall low CD4 counts. Other factors remain to be elucidated.  相似文献   
96.
Murine plasmacytoid dendritic cells (pDCs) have been credited with a unique ability to express indoleamine 2,3-dioxygenase (IDO) function and mediate immunosuppression in specific settings; yet, the conditions of spontaneous versus induced activity have remained unclear. We have used maneuvers known to up-regulate IDO in different cell types and have examined the relative efficacy and mechanisms of the induced activity in splenic pDCs, namely, after specific receptor engagement by CTLA-4-Ig, CD200-Ig or CD28-Ig, the latter in combination with silenced expression of the suppressor of cytokine signaling 3 (SOCS3) gene. We found that pDCs (CD11c+ mPDCA-1+ 120G8+) do not express IDO and are not tolerogenic under basal conditions. B7-1 engagement by CTLA-4-Ig, CD200R1 engagement by CD200-Ig and B7-1/B7-2 engagement by CD28-Ig in SOCS3-deficient pDCs were each capable of initiating IDO-dependent tolerance via different mechanisms. IFN-gamma was the major cytokine responsible for CTLA-4-Ig effects, and type I IFNs for those of CD200-Ig. Immunosuppression by CD28-Ig in the absence of SOCS3 required IFN-gamma induction and IFN-like actions of IL-6. Therefore, although pDCs do not mediate IDO-dependent tolerance constitutively, multiple ligands and cytokines will contribute to the expression of a tolerogenic phenotype by pDCs in the mouse.  相似文献   
97.
CD1d deficiency exacerbates inflammatory dermatitis in MRL-lpr/lpr mice   总被引:2,自引:0,他引:2  
Mechanisms responsible for the development of autoimmune skin disease in humans and animal models with lupus remain poorly understood. In this study, we have investigated the role of CD1d, an antigen-presenting molecule known to activate natural killer T cells, in the development of inflammatory dermatitis in lupus-susceptible MRL-lpr/lpr mice. In particular, we have established MRL-lpr/lpr mice carrying a germ-line deletion of the CD1d genes. We demonstrate that CD1d-deficient MRL-lpr/lpr mice, as compared with wild-type littermates, have more frequent and more severe skin disease, with increased local infiltration with mast cells, lymphocytes and dendritic cells, including Langerhans cells. CD1d-deficient MRL-lpr/lpr mice had increased prevalence of CD4(+) T cells in the spleen and liver and of TCR alpha beta (+)B220(+) cells in lymph nodes. Furthermore, CD1d deficiency was associated with decreased T cell production of type 2 cytokines and increased or unchanged type 1 cytokines. These findings indicate a regulatory role of CD1d in inflammatory dermatitis. Understanding the mechanisms by which CD1d deficiency results in splenic T cell expansion and cytokine alterations, with increased dermal infiltration of dendritic cells and lymphocytes in MRL-lpr/lpr mice, will have implications for the pathogenesis of inflammatory skin diseases.  相似文献   
98.
Despite advances in our understanding of tumour immunology there is no therapy of proven survival benefit for advanced melanoma. Nevertheless, disease progression is slow in a small proportion of patients with metastatic melanoma, suggesting a contribution to outcome from host factors. Recent data have indicated the importance of the heat shock protein receptor CD91 in immune responses to, and progression of, infectious disease. Here we investigate the relationship between CD91 expression and outcome in malignancy. Rare melanoma patients were recruited with advanced disease that was progressing unusually slowly. CD91 expression on their monocytes was compared with control patients with more typical rapidly advancing metastatic disease. Th1 and Th2 cytokines, as well as innate and adaptive immune subsets, were also measured in the two groups. A significant increase in median CD91 expression levels was observed in slow progressors (P = 0.006). There were no differences in other immune subset markers or inflammatory cytokines. The ability of CD91 to internalize and cross-present tumour antigens through the major histocompatibility complex class I pathway may maintain CD8-positive cytotoxic T cell responses and contribute to slow progression of advanced melanoma.  相似文献   
99.
Dissecting the complexity of the memory T cell response   总被引:2,自引:0,他引:2  
Memory immune responses are classically attributed to the reactivation of long-lived, antigen-specific T lymphocytes that persist in a quiescent state. Determining mechanisms for the generation of memory T cells and dissecting the functional nature of the memory T cell pool has been encumbered by an inability to distinguish recently activated effector T cells from memory T cells. We have established new activation and biochemical criteria that distinguish effector and memory T cells and have applied these criteria to follow memory generation from activated cells in vivo. We found that the resultant memory T cell pool is heterogeneous and consists of effector-like and resting memory-like subsets that differ in expression of the homing receptor, CD62L. We discuss these findings in the context of memory T cell heterogeneity identified in human and mouse systems. These results suggest that more than one type of previously activated T cell can mediate recall or memory immune responses and that elucidating the fundamental phenotypic and functional features of memory T cell subsets is therefore critical to deciphering the complex nature of the memory immune response.  相似文献   
100.
目的: 分析多发性硬化(MS)进展型患者不同表型NK细胞亚群对临床主要治疗方法的反应性差异.方法: 分离患者外周血中的NK细胞, 以流式细胞术根据表面抑制性受体CD94/NKG2A表达情况分为两个亚群CD94/NKG2A-bright和CD94/NKG2A-dim.分别加入IFN-β, 测定两个亚群表面CD94/NKG2A变化及细胞增殖, 同时检测两种亚群分泌IL-10和TGF-β情况.结果: CD94/NKG2A阳性表达的NK细胞占25.5%, 其中CD94/NKG2A-bright和CD94/NKG2A-dim分别占其中的23.6%和76.4%.加入IFN-β, CD94/NKG2A-bright组增殖率明显低于CD94/NKG2A-dim组, CD94/NKG2A表达峰度变化不大.CD94/NKG2A-dim组中CD94/NKG2A表达显著增加.两个亚群分泌的IL-10和TGF-β与未刺激组相比, 均有明显差异.CD94/NKG2A-bright和CD94/NKG2A-dim组间亦有明显差异.结论: IFN-β通过诱导NK细胞CD94/NKG2A表达在非特异免疫系统中抑制NK细胞; 同时刺激IL-10 和TGF-β分泌进一步发挥对免疫系统的抑制.CD94/NKG2A-bright和CD94/NKG2A-dim对IFN-β反应有差异性.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号